Connect with us

National

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection – News-Medical.Net

Researchers at the Infection Biology Unit, German Primate Center, and the Georg-August-University Göttingen in Germany have found that the B.1.351 and P.1 SARS-CoV-2…

Published

on

Article feature image

Coronavirus disease 2019 (2019) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Over a year into the COVID-19 pandemic, new variants of concern have emerged and posed serious health threats globally. These new variants have exhibited heightened transmissibility and immunity evasion potential.
In a new study, published in the journal Cell, researchers in Germany found that the variants B.1.1.7 (or United Kingdom) variant, the B.1.351 (or South African)…

Click here to view the original article.